Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7193-7201

  Park, Hyewon ^a   Jung, Youn Kwan ^b   Park, Ok Jin ^a   Lee, Yeon Ju ^a   Choi, Je Yong ^b   Choi, Youngnim ^a  

^a Seoul National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOKINE; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 28244491672     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7193     Document Type: Article

References (43)

1. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
2. Takayanagi. H.,S. Kim, T. Koga, and T. Taniguchi. 2005. Statl-mediated cytoplasmic attenuation in osteoimmunology. J. Cell. Biochem. 94: 232-240.
3. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L. D. Shultz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
4. Kodama, H., M. Nose, S. Niida, and A. Yamasaki. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med. 173: 1291-1294.
5. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
6. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
7. Dougall, W. C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, et al. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424.
8. Saidenberg Kermanac'h, N., N. Bessis, M. Cohen-Solal, M. C. De Vernejoul, and M. C. Boissier. 2002. Osteoprotegerin and inflammation. Eur. Cytokine Network 13: 144-153.
9. Katagiri, T., and N. Takahashi. 2002. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 8: 147-159.
10. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
11. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
12. + T cells. Eur. J. Immunol 31: 2179-2188.
13. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365.
14. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
15. Wu, X., M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald. 2003. Osteoclast apoptosis: the role of Fas in vivo and in vitro. Endocrinology 144: 5545-5555.
16. Wu, X., G. Pan, M. A. McKenna, M. Zayzafoon, X.-C. Xiong, and J. M. McDonald. 2005. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. J. Bone Miner. Res. 20: 107-116.
17. Fox, S. W., and T. J. Chambers. 2000. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 276: 868-872.
18. Choi, J.-Y., A. J. van Wijnen, F. Asian, J. D. Leszyk, J. L. Stein, G. S. Stein, J. B. Lian, and S. Penman. 1998. Developmental association of the β-galactoside-binding protein galectin-1 with the nuclear matrix of rat calvarial osteoblasts. J. Cell Sci. 111: 3035-3043.
19. Choi, Y., K. Simon-Stoos, and J. M. Puck. 2002. Hypo-active variant of IL-2 and associated decreased T cell activation contribute to impaired apoptosis in autoimmune prone MRL mice. Eur. J. Immunol. 32: 677-685.
20. Choi, J.-Y., J. Pratap, A. Javed, S. K. Zaidi, L. Xing, E. Balint, S. Dalamangas, B. Boyce, A. J. van Wijnen, J. B. Lian, et al. 2001. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. USA 98: 8650-8655.
21. Park, D. R., A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles. 2003. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170: 6209-6216.
22. Imamura, R., K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita, and T, Suda. 2004. Fas ligand induces cell-autonomous NF-κB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-α. J. Boil. Chem. 279: 46415-46423.
23. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154: 3806-3813.
24. Vasudevan, S. S., N. H. Lopes, P. N. Seshiah, T. Wang, C. B. Marsh, D. J. Kereiakes, C. Dong, and P. J. Goldschmidt-Clermont. 2003. Mac-1 and Fas activities are concurrently required for execution of smooth muscle cell death by M-CSF-stimulated macrophages. Cardiovasc. Res. 59: 723-733.
25. Schneider, P., J. L. Bodmer, N. Holler. C. Mattmann, P. Scuderi, A. Terskikh, M. C. Peitsch, and J. Tschopp. 1997. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J. Biol. Chem. 272: 18827-18833.
26. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
27. Yang, C. R., J. H. Wang, S. L. Hsieh, S. M. Wang, T. L. Hsu, and W. W. Lin. 2004. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death Differ Suppl. 1 : S97-S107.
28. Wallach, D., T. U. Arumugam, M. P. Boidin, G. Cantarella, K. A. Ganesh, Y. Goltsev, T. M. Goncharov, A. V. Kovalenko, A. Rajput, E. E. Varfolomeev, and S. Q. Zhang. 2002. How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family. Arthritis Res. Suppl. 3: S189-S196.
29. Hohibaum, A. M., R. R. Saff, and A. Marshak-Rothstein. 2002. Fas-ligand: iron fist or Achilles' heel? Clin. Immunol. 103: 1-6.
30. Saas, P., J. Boucraut, A. I. Quiquerez, V. Schnuriger, G. Perrin, S. Desplat-Jego, D. Bernard, P. R. Walker, and P. Y. Dietrich. 1999. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J. Immunol. 162: 2326-2333.
31. Rescigno, M., V. Piguet, B. Valzasina, S. Lens, R. Zubler, L. French, V. Kindler, J. Tschopp, and P. Ricciardi-Castagnoli. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-Iβ, and the production of interferon γ in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192: 1661-1668.
32. Tsutsui, H., N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, et al. 1999. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11: 359-367.
33. Sekine, C., H. Yagita, T. Kobata, T. Hasunuma, K. Nishioka, and K. Okumura. 1996. Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem. Biophys. Res. Commun. 228: 14-20.
34. Miwa, K., M. Asano, R. Horai, Y. Iwakura, S. Nagata, and T. Suda. 1998. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 4: 1287-1292.
35. Hagimoto, N., K. Kuwano, M. Kawasaki, M. Yoshimi, Y. Kaneko, R. Kunitake, T. Maeyama, T. Tanaka, and N. Hara. 1999. Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am. J. Respir. Cell Mol. Biol. 21: 436-445.
36. Schaub, F. J., D. K. Han, W. C. Liles, L. D. Adams, S. A. Coats, R. K. Ramachandran, R. A. Seifert, S. M. Schwartz, and D. F. Bowen-Pope. 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6: 790-796.
37. Ma, T., K. Miyanishi, A. Suen, N. J. Epstein, T. Tomita, R. L. Smith, and S. B. Goodman. 2004. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-α. Cytokine 26: 138-144.
38. Nanes, M. S. 2003. Tumor necrosis factor-α; molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15.
39. Hu, W.-H., H. Johnson, and H.-B. Shu. 2000. Activation of NF-κB by FADD, Casper, and Caspase-8. J. Boil. Chem. 275: 10838-10844.
40. Qin, Y., B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann. 2002. Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation. J. Immunol. 169: 3536-3544.
41. Ishikawa, T., M. Kamiyama, N. Tani-Ishii, H. Suzuki, Y. Ichikawa, Y. Hamaguchi, N. Momiyama, and H. Shimada. 2001. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol. Carcinog. 32: 84-91.
42. Ozeki, N., M. Mogi, H. Nakamura, and A. Togari. 2002. Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch. Oral Biol. 47: 511-517.
43. Katavic, V., I. K. Lukic, N. Kovacic, D. Grcevic, J. A. Lorenzo, and A. Marusic. 2003. Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. J. Immunol. 170: 1540-1547.